Tag: EU Joint Clinical Assessment HTA 2025

Pharma Market Access 2025: HTA, U.S. Drug Pricing, and Tariffs
Jul 2, 2025
—
by
wlcus_admin
in Pharma
Global Pharma Market Access Under Pressure Pharma market access is no longer just a regulatory hurdle, it’s a geopolitical challenge. With the EU’s new HTA regulation, U.S. pricing reforms, potential […]